Bridgeway Capital Management’s Minerva Neurosciences NERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,436
Closed -$24.5K 1413
2022
Q4
$24.5K Sell
15,436
-712
-4% -$1.13K ﹤0.01% 1330
2022
Q3
$149K Hold
16,148
﹤0.01% 1201
2022
Q2
$53K Sell
16,148
-2
-0% -$7 ﹤0.01% 1278
2022
Q1
$107K Sell
16,150
-6,214
-28% -$41.2K ﹤0.01% 1253
2021
Q4
$143K Sell
22,364
-1,286
-5% -$8.22K ﹤0.01% 1192
2021
Q3
$329K Buy
23,650
+12,500
+112% +$174K 0.01% 1135
2021
Q2
$207K Sell
11,150
-18,067
-62% -$335K ﹤0.01% 1256
2021
Q1
$683K Sell
29,217
-688
-2% -$16.1K 0.01% 1006
2020
Q4
$560K Buy
29,905
+11,125
+59% +$208K 0.01% 904
2020
Q3
$478K Buy
+18,780
New +$478K 0.01% 905
2020
Q1
Sell
-9,338
Closed -$531K 1335
2019
Q4
$531K Hold
9,338
0.01% 957
2019
Q3
$579K Buy
9,338
+25
+0.3% +$1.55K 0.01% 888
2019
Q2
$419K Hold
9,313
0.01% 1025
2019
Q1
$586K Hold
9,313
0.01% 980
2018
Q4
$502K Sell
9,313
-2,587
-22% -$139K 0.01% 1003
2018
Q3
$1.2M Sell
11,900
-6,250
-34% -$628K 0.01% 809
2018
Q2
$1.2M Hold
18,150
0.01% 809
2018
Q1
$908K Buy
18,150
+525
+3% +$26.3K 0.01% 886
2017
Q4
$853K Hold
17,625
0.01% 899
2017
Q3
$1.07M Hold
17,625
0.01% 825
2017
Q2
$1.25M Buy
17,625
+7,625
+76% +$540K 0.02% 743
2017
Q1
$648K Hold
10,000
0.01% 972
2016
Q4
$940K Sell
10,000
-6,512
-39% -$612K 0.01% 848
2016
Q3
$1.87M Sell
16,512
-4,825
-23% -$545K 0.03% 557
2016
Q2
$1.74M Buy
21,337
+9,950
+87% +$813K 0.03% 575
2016
Q1
$559K Buy
11,387
+2,500
+28% +$123K 0.01% 995
2015
Q4
$432K Buy
8,887
+4,119
+86% +$200K 0.01% 1106
2015
Q3
$200K Buy
4,768
+2,268
+91% +$95.1K ﹤0.01% 1309
2015
Q2
$116K Buy
+2,500
New +$116K ﹤0.01% 1417